India, Aug. 17 -- Today's top gainers in the biotech and medical technology space include 4D Molecular Therapeutics, following Phase 3 progress and strong clinical data; OmniAb, after securing a collaboration with Eli Lilly and raising its cash outlook; Acurx Pharmaceuticals, following FDA acceptance of its proposed ibezapolstat brand name; Intelligent Bio Solutions, after ISO recertification; and Profusa, following a reverse stock split, among others.
FDMT Advances On Pipeline Progress
4D Molecular Therapeutics, Inc. (FDMT) gained more than 12% following its second-quarter 2026 results and operational updates. The clinical-stage biotechnology company completed enrollment in the global Phase 3 4FRONT-2 trial of 4D-150 for wet age-related ...